Moncef Slaoui Fired From GSK Role After Sexual Harassment Inquiry
Allegations Substantiated By External Investigators
Executive Summary
External investigation is ongoing, and GSK is reviewing claw-back options for remaining financial ties that firm has with Slaoui, who issued an apology and has taken a leave from his new role at Centessa Pharmaceuticals.
You may also be interested in...
Centessa Looks To Transform Drug Development With ‘Asset Centric’ Model
In an interview with Scrip, CEO Saurabh Saha elaborates on the first-of-its-kind R&D model.
Novartis Nominates Ex-BMS Chief As It Pursues US Growth Strategy
The Swiss pharma company is looking to tap into the experience of ex-BMS leader Giovanni Caforio to help further it US-first commercial strategy.
Corbus And Janux Lead Q1’s Small-Cap Winners
Corbus has presence in both antibody drug conjugates and obesity, and was the stand-out small-cap target for investors with a fivefold increase in its share price in Q1.